Cellular Biomedicine Group, Inc. Current Ratio 2010-2020 | CBMG
Cellular Biomedicine Group, Inc. current ratio from 2010 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2020-09-30 |
$0.03B |
$0.06B |
0.47 |
2020-06-30 |
$0.02B |
$0.03B |
0.53 |
2020-03-31 |
$0.02B |
$0.02B |
1.00 |
2019-12-31 |
$0.03B |
$0.02B |
1.44 |
2019-09-30 |
$0.05B |
$0.03B |
1.87 |
2019-06-30 |
$0.06B |
$0.02B |
2.68 |
2019-03-31 |
$0.07B |
$0.02B |
4.43 |
2018-12-31 |
$0.06B |
$0.01B |
6.79 |
2018-09-30 |
$0.07B |
$0.01B |
11.86 |
2018-06-30 |
$0.04B |
$0.01B |
7.82 |
2018-03-31 |
$0.05B |
$0.01B |
9.35 |
2017-12-31 |
$0.02B |
$0.00B |
6.47 |
2017-09-30 |
$0.02B |
$0.00B |
4.94 |
2017-06-30 |
$0.03B |
$0.01B |
6.50 |
2017-03-31 |
$0.04B |
$0.00B |
17.62 |
2016-12-31 |
$0.04B |
$0.00B |
17.21 |
2016-09-30 |
$0.05B |
$0.00B |
23.51 |
2016-06-30 |
$0.05B |
$0.00B |
22.37 |
2016-03-31 |
$0.02B |
$0.00B |
5.58 |
2015-12-31 |
$0.02B |
$0.00B |
5.53 |
2015-09-30 |
$0.02B |
$0.01B |
4.60 |
2015-06-30 |
$0.03B |
$0.01B |
4.89 |
2015-03-31 |
$0.03B |
$0.01B |
6.48 |
2014-12-31 |
$0.02B |
$0.00B |
3.95 |
2014-09-30 |
$0.01B |
$0.01B |
2.27 |
2014-06-30 |
$0.01B |
$0.00B |
5.65 |
2014-03-31 |
$0.01B |
$0.00B |
3.62 |
2013-12-31 |
$0.01B |
$0.00B |
3.44 |
2013-09-30 |
$0.00B |
$0.00B |
2.03 |
2013-06-30 |
$0.00B |
$0.00B |
1.09 |
2013-03-31 |
$0.01B |
$0.00B |
1.76 |
2012-12-31 |
$0.00B |
$0.00B |
7.31 |
2012-09-30 |
$0.00B |
$0.01B |
0.01 |
2012-06-30 |
$0.00B |
$0.00B |
0.07 |
2012-03-31 |
$0.00B |
$0.00B |
0.19 |
2011-12-31 |
$0.00B |
$0.00B |
0.31 |
2011-09-30 |
$0.00B |
$0.00B |
0.01 |
2011-06-30 |
$0.00B |
$0.00B |
0.03 |
2011-03-31 |
$0.00B |
|
0.00 |
2010-12-31 |
$0.00B |
|
0.00 |
2010-09-30 |
$0.00B |
|
0.00 |
2010-06-30 |
$0.00B |
|
0.00 |
2010-03-31 |
$0.00B |
|
0.00 |
2009-12-31 |
$0.00B |
|
0.00 |
2009-09-30 |
$0.00B |
|
0.00 |
2009-06-30 |
$0.00B |
|
0.00 |
2009-03-31 |
$0.00B |
|
0.00 |